Enhanced External Counterpulsation (EECP) Coverage Criteria
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage guidelines for outpatient use of Enhanced External Counterpulsation (EECP) for Medicare Advantage and Commercial members; defines medical necessity, prior authorization guidance, coding, and device background.
No material clinical or coverage changes in this revision.
Coverage criteria for EECP
inv-01: Initial Therapy (Commercial Products)
Covered when ALL of the following are met:
See definition of single course
inv-02: Repeat Therapy
Repeat course considered medically necessary when ALL of the following are met:
Repeat courses reserved for responders
Enhanced External Counterpulsation (EECP) is not medically necessary for cardiac indications that are not specifically listed in this policy. The policy states that EECP is considered not medically necessary for all other cardiac indications not otherwise specified and for any indications that do not meet the stated medical criteria for coverage (see criteria for chronic disabling angina and repeat therapy).
If services are determined to be not medically necessary (or are medically necessary but non‑covered benefits), the provider may not charge the member for those services unless the member has been informed and has agreed in writing in advance to self‑pay. Verify member benefits and eligibility with the provider call center and follow the member's subscriber or employer agreement, which supersedes this medical policy.
The use of EECP is not medically necessary for indications other than chronic disabling stable angina (Class III or IV CCS or equivalent) that meet the policy's specified criteria. EECP should only be considered when the defined clinical criteria are satisfied; services for other cardiac or non‑listed indications are excluded from medical necessity under this policy.
When EECP (or any service) is determined to be not medically necessary, providers must obtain a written agreement from the member before billing the member directly. The member must be informed and must agree in writing in advance to continue treatment at their own expense; review participation agreements for applicable provisions.
Coding and treatment parameters
| G0166 | External counterpulsation, per treatment session |
| G0166 | External counterpulsation, per treatment session |
| G0166 | External counterpulsation, per treatment session |
Provider requirements, prior auth, and billing notes
Prior authorization recommended for Commercial Products
Prior authorization is recommended for Commercial Products; Medicare Advantage plans are noted as not applicable for prior authorization guidance.
Coverage and billing code: G0166
Use HCPCS code G0166 (External counterpulsation, per treatment session) for Commercial Products when the policy's medical criteria are met; verify member benefits and any prior authorization requirements per the subscriber agreement.
- Code: G0166 — External counterpulsation, per treatment session
Exhaust optimal medical therapy before EECP
Must document that the individual is refractory to optimal medical therapy before EECP is considered.
- Documentation must show failure or refractoriness to optimal medical therapy and that the condition is not readily amenable to PTCA or CABG (inoperable, high operative risk, or unfavorable coronary anatomy).
Procedure supervision and course length
Ensure the procedure will be performed under direct physician supervision and that the single course definition (35 hours) is met when applicable.
- A single course consists of a total of 35 hours (35 one‑hour treatments given 1–2 hours daily, 5 days/week).
Required clinical documentation
Document clinical findings that support Class III or IV CCS angina, refractoriness to optimal medical therapy, unsuitability for revascularization (inoperable/high operative risk or coronary anatomy not amenable), absence of contraindicating comorbid conditions, and that treatment will be under direct physician supervision. For repeat courses, document objective response to prior EECP (improved radionuclide stress perfusion imaging, reduced antianginal medication use, or improved exercise tolerance).
- Class III or IV Canadian Cardiovascular Society angina (or equivalent).
- Evidence patient is refractory to optimal medical therapy and not a candidate for PTCA/CABG.
- Absence of contraindications (e.g., aortic insufficiency, arrhythmias, uncontrolled bleeding diathesis, severe heart failure, DVT/varicosities, peripheral vascular disease, severe hypertension, stroke).
- For repeat therapy: objective response such as improved radionuclide stress perfusion imaging, reduced antianginal meds, or improved exercise tolerance.
Verify member eligibility and benefits
Verify member benefits and eligibility with the provider call center; benefits and eligibility are determined by the member's subscriber agreement or employer agreement which supersede this medical policy.
Denial triggers — unmet criteria or contraindications
EECP is not medically necessary when the policy's medical criteria are not met or for indications not listed; presence of contraindicating comorbid conditions (for example: aortic insufficiency; arrhythmias including AF, Aflutter, VT, frequent PVCs; uncontrolled bleeding diathesis; severe heart failure; deep vein thrombosis, varicosities, stasis ulcers; peripheral vascular disease, phlebitis; severe hypertension; stroke) may result in denial.
- Services for indications other than chronic disabling angina meeting the specified criteria are considered not medically necessary.
- Contraindicating comorbid conditions listed above increase risk and may trigger denial.
Member financial responsibility if service not medically necessary
If services are determined to be not medically necessary (or are medically necessary but non‑covered benefits), you may not charge the member for the services unless the member has been informed and agreed in writing in advance to self‑pay.
Background on Enhanced External Counterpulsation (EECP)
Enhanced External Counterpulsation (EECP) is a noninvasive outpatient therapy that uses timed, sequential inflation of pressure cuffs on the calves, thighs, and buttocks to augment diastolic arterial pressure, reduce left ventricular afterload, increase venous return, and thereby enhance coronary perfusion and collateral development. A standard single course consists of 35 one‑hour treatments (total = 35 hours), typically delivered one to two hours daily, five days per week over approximately 3½ to 7 weeks. EECP has been studied primarily for refractory chronic stable angina and heart failure, and symptomatic benefits have been reported to persist for months to years in some studies.
Key definitions used in this policy
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.